TCL Archive NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS December 19, 1997
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response November 29, 2013
TCL Archive In Brief: Panel Meeting Canceled; New Senior Executive Service Draws Enthusiastic Response At NCI July 13, 1979
